VC
QTTB icon

Vivo Capital’s Q32 Bio QTTB Stock Holding History

Vivo Capital’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,559
Closed -$70.7K – 43
2024
Q4 		$70.7K Hold
20,559
– – 0.01% 39
2024
Q3 		$917K Hold
20,559
– – 0.08% 41
2024
Q2 		$369K Sell
20,559
-349,509
-94% -$8.36M 0.03% 41
2024
Q1 		$6.31M Buy
370,068
+349,509
+1,700% +$4.82M 0.5% 34
2023
Q4 		$225K Hold
20,559
– – 0.02% 46
2023
Q3 		$433K Hold
20,559
– – 0.05% 52
2023
Q2 		$328K Hold
20,559
– – 0.02% 47
2023
Q1 		$381K Hold
20,559
– – 0.03% 47
2022
Q4 		$466K Hold
20,559
– – 0.05% 47
2022
Q3 		$596K Hold
20,559
– – 0.07% 49
2022
Q2 		$729K Sell
20,559
-26,838
-57% -$916K 0.07% 47
2022
Q1 		$2.59M Hold
47,397
– – 0.18% 47
2021
Q4 		$3.1M Hold
47,397
– – 0.19% 50
2021
Q3 		$6.71M Hold
47,397
– – 0.3% 46
2021
Q2 		$6.2M Hold
47,397
– – 0.27% 50
2021
Q1 		$8.03M Hold
47,397
– – 0.28% 49
2020
Q4 		$9.63M Hold
47,397
– – 0.43% 42
2020
Q3 		$9.13M Sell
47,397
-1,253
-3% -$281K 0.53% 41
2020
Q2 		$13.3M Sell
48,650
-7,381
-13% -$1.97M 0.95% 29
2020
Q1 		$15.7M Buy
+56,031
New +$17.2M 1.42% 21
2019
Q3 		– Sell
-64,430
Closed -$22.7M – 31
2019
Q2 		$22.7M Hold
64,430
– – 2.13% 16
2019
Q1 		$32.2M Hold
64,430
– – 3.21% 9
2018
Q4 		$25.9M Hold
64,430
– – 3.31% 8
2018
Q3 		$26.5M Sell
64,430
-13,889
-18% -$4.72M 2.67% 12
2018
Q2 		$28.8M Buy
78,319
+13,889
+22% +$4.97M 3.71% 9
2018
Q1 		$21.7M Buy
+64,430
New +$21.7M 3.07% 8

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Vivo Capital's QTTB Position: Q1 2025 in Review

Vivo Capital sold out of Q32 Bio (QTTB) in Q1 2025, closing a stake of 20,559 shares — an estimated $70.7K sold.

Vivo Capital first reported a position in QTTB in Q1 2018 and held it in 26 quarters. The position peaked at $32.2M in Q1 2019. 73 funds tracked by Wall St. Rank hold QTTB as of Q1 2025.

  • Vivo Capital reported no remaining Q32 Bio position as of Q1 2025 after selling out during the quarter.
  • Vivo Capital sold 20,559 Q32 Bio shares in Q1 2025, an estimated $70.7K.
  • Vivo Capital first reported a position in Q32 Bio in Q1 2018 and held it in 26 quarters.
  • Vivo Capital's Q32 Bio position peaked at $32.2M in Q1 2019.
  • 73 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2025.

Based on Vivo Capital's 13F filing for Q1 2025, filed 12 May 2025.